Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02278120
Title	Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)
Acronym	MONALEESA-7
Recruitment	Completed
Gender	female
Phase	Phase III
Variant Requirements	No
Sponsors	Novartis Pharmaceuticals
Indications	Her2-receptor negative breast cancer
Therapies	Goserelin + Ribociclib + Tamoxifen Goserelin + Tamoxifen Anastrozole + Goserelin Goserelin + Letrozole Goserelin + Letrozole + Ribociclib Anastrozole + Goserelin + Ribociclib
Age Groups:	adult
Covered Countries	USA \| TUR \| POL \| LBN \| ITA \| HUN \| GRC \| FRA \| ESP \| DEU \| CHE \| CAN \| BRA \| BGR \| BEL \| AUS \| ARG